The bioavailability of three commercial brands of rifampicin capsules was tested in complete crossover fashion in six- healthy male volunteers each receiving 600 mg of the drug. The serum concentrations of rifampicin were determined at 0.5, 1, 2, 4, 6, 8, and 10 hours after the administration of drug using high performance liquid chromatography. The pharmacokinetics and bioavailability parameters of three brands i.e. brand A (Rifapin, Schazoo Laboratories Ltd., Lahore), brand B (Rifampicin, Lahore Chemical and Pharmaceutical Works (Pvt), Ltd., Lahore) and brand C (Rifampicin, Pliva Pharmaceutical, Yogoslavia) were compared. Variations observed in the values of Cmax 13 and Vd could be attributed to the differences in formulations and manufacturing processes.